These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. T cell receptor beta-chain third complementarity-determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease. Talken BL; Holyst MM; Lee DR; Hoffman RW Arthritis Rheum; 1999 Apr; 42(4):703-9. PubMed ID: 10211884 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies--what do they recognize? Tan EM Verh Dtsch Ges Pathol; 1996; 80():1-11. PubMed ID: 9020568 [No Abstract] [Full Text] [Related]
4. Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease. McHugh N; James I; Maddison P J Rheumatol; 1990 Oct; 17(10):1320-8. PubMed ID: 1701488 [TBL] [Abstract][Full Text] [Related]
5. Mapping of multiple B cell epitopes on the 70-kilodalton autoantigen of the U1 ribonucleoprotein complex. Cram DS; Fisicaro N; Coppel RL; Whittingham S; Harrison LC J Immunol; 1990 Jul; 145(2):630-5. PubMed ID: 1694884 [TBL] [Abstract][Full Text] [Related]
6. Molecular mimicry and autoantigens in connective tissue diseases. Horsfall AC Mol Biol Rep; 1992 Jun; 16(3):139-47. PubMed ID: 1380637 [No Abstract] [Full Text] [Related]
7. Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. Mahler M; Blüthner M; Pollard KM Clin Immunol; 2003 May; 107(2):65-79. PubMed ID: 12763475 [TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of autoantibodies to soluble intra-cellular protein antigens in systemic connective tissue diseases]. Abe T; Takano M Ryumachi; 1987 Jun; 27(3):203-14. PubMed ID: 2449738 [No Abstract] [Full Text] [Related]
9. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases. Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764 [TBL] [Abstract][Full Text] [Related]
11. The role of autoantigens in the driving of autoimmune diseases. Roitt IM Immunol Ser; 1993; 59():119-29. PubMed ID: 7681695 [No Abstract] [Full Text] [Related]
12. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772 [TBL] [Abstract][Full Text] [Related]
13. Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe? Zheng WJ; Zhang X; Wang Q; Xu D; Zeng XF; Zhang FC Ann Rheum Dis; 2009 Jun; 68(6):1077-8. PubMed ID: 19435726 [No Abstract] [Full Text] [Related]
14. Do autoantibodies inhibit function of their cognate antigens in vivo? Tan EM Arthritis Rheum; 1989 Jul; 32(7):924-5. PubMed ID: 2751724 [No Abstract] [Full Text] [Related]
15. [Antibodies against soluble nuclear antigens ENA, RNP and Sm: comparison of different detection methods in collagen diseases (author's transl)]. Rivero S; Sánchez G Rev Med Chil; 1981 Aug; 109(8):711-6. PubMed ID: 6177024 [No Abstract] [Full Text] [Related]
16. [General pathology of autoimmunity in the human]. Haferkamp O Internist (Berl); 1990 Jan; 31(1):9-18. PubMed ID: 1689706 [No Abstract] [Full Text] [Related]
17. Antibodies to heterogeneous nuclear ribonucleoprotein H1 are directed to RNA recognition motif 3. Op de Beéck K; Van den Bergh K; Westhovens R; Verschueren P; Hooijkaas H; van de Merwe JP; Michiels G; Schlumberger W; Blockmans D; Bossuyt X Rheumatology (Oxford); 2011 Mar; 50(3):621-2. PubMed ID: 21258048 [No Abstract] [Full Text] [Related]